Motley Fool – Earnings Transcripts
Full earnings call transcripts from The Motley Fool
Penguin Solutions Inc (PENG) Q2 2026 Earnings Call Transcript
Penguin Solutions reported Q1 fiscal 2026 revenue of $343 million, up 2% sequentially and 1% year‑over‑year, despite the absence of hyperscale hardware sales. Non‑GAAP gross margin slipped to 30% as the high‑margin Penguin Edge business winds down, while Integrated Memory surged 41% YoY, offsetting a 15% decline in Advanced Computing. The company maintained its full‑year guidance of 6% net‑sales growth and $2 non‑GAAP EPS, highlighted new enterprise contracts, and announced the sale of its remaining 19% stake in Zilia Technologies for $46 million. Cash, equivalents and short‑term investments rose to $461 million, and the cash conversion cycle improved to 35 days.
Franklin Covey Co (FC) Q2 2026 Earnings Call Transcript
Franklin Covey reported Q2 2026 revenue of $64 million, a 7% decline year‑over‑year, primarily due to an 8% drop in Enterprise and a 2% dip in Education. Despite the revenue dip, Enterprise North America invoiced amounts grew 7% overall and 13%...
Tilray Brands Inc (TLRY) Q3 2026 Earnings Call Transcript
Tilray Brands reported Q1 FY2026 net revenue of $210 million, a 5% year‑over‑year increase, and returned to net profitability with $1.5 million net income. Gross margin slipped to 27% from 30% last year, driven by lower margins in the beverage and cannabis...
Jupiter Neurosciences Inc (JUNS) Q4 2025 Earnings Call Transcript
Jupiter Neurosciences reported total product sales of $2.8 billion in 2025, a 22% year‑over‑year increase driven by INGREZZA and the debut of CRENESSITY. INGREZZA generated just over $2.5 billion, up 9% on volume growth, while CRENESSITY posted $300 million in its first full...
UniFirst Corp (UNF) Q2 2026 Earnings Call Transcript
Upexi reported a Q2 net loss of $178.9 million, driven largely by a $86.4 million unrealized loss as Solana’s price dropped 40% during the quarter. Revenue rose to $8.1 million, more than doubling year‑over‑year, while the company added roughly 106,000 Solana tokens to...
NCino Inc (NCNO) Q4 2026 Earnings Call Transcript
nCino reported second‑quarter fiscal 2026 revenue of $148.8 million, a 12% year‑over‑year increase, with subscription revenue climbing 15% to $130.8 million and organic growth of 10%. Mortgage and non‑U.S. subscription revenues surged 22% and 30% respectively, while platform pricing conversion reached 21%...
Dave and Buster's Entertainment, Inc (PLAY) Q4 2026 Earnings Call Transcript
Best Buy reported Q4 fiscal 2026 revenue of $13.8 billion, a 1% decline, while adjusted operating income rose to a 5% rate, delivering $2.61 earnings per share, up 1%. Comparable sales slipped 0.8% but stayed inside the company’s guidance range. The...
Gohealth Inc (GOCO) Q4 2025 Earnings Call Transcript
AdaptHealth Corp. reported 2025 net revenue of $3.245 billion and adjusted EBITDA of $616.7 million, both beating guidance midpoints despite a slight year‑over‑year revenue dip. Organic growth was modest at 1.7%, while sleep and respiratory segments delivered double‑digit revenue gains and record...
Imunon Inc (IMNN) Q4 2025 Earnings Call Transcript
Imunon reported Q3 2025 results, highlighting $5.3 million cash and a runway extending to mid‑Q1 2026 after a $4.5 million equity raise. Operating expenses fell 31% year‑over‑year, reducing monthly burn to $1.25‑$1.5 million. The pivotal OVATION 3 phase III ovarian‑cancer trial enrolled nine patients, surpassing internal targets,...
Tevogen Bio Holdings Inc (TVGN) Q4 2025 Earnings Call Transcript
VistaGen Therapeutics reported completing the randomized portion of its PALISADE III Phase 3 trial and using the data to implement operational and statistical refinements for the ongoing PALISADE IV study. The company is leveraging third‑party AI and machine learning to...
Tvardi Therapeutics Inc (TVRD) Q4 2025 Earnings Call Transcript
Teva reported Q4 2025 revenue of $4.5 billion, up 3% year‑over‑year, with adjusted EBITDA rising 6% and non‑GAAP EPS of $0.78, a 14% increase. The innovative portfolio contributed over $800 million, driven by AUSTEDO’s $618 million U.S. sales (+38%) and solid gains from...
LENSAR Inc (LNSR) Q4 2025 Earnings Call Transcript
National Vision Holdings reported FY2025 net revenue of $1.99 billion, a 9% increase year‑over‑year, driven by a 6% rise in comparable store sales and a 56% jump in adjusted operating income to $102.5 million. The company expanded its operating margin to 5.2%...
Connect Biopharma Holdings Ltd (CNTB) Q4 2025 Earnings Call Transcript
ConnectOne Bancorp reported $14 billion in assets and a market capitalization above $1.4 billion after completing its largest acquisition and a rapid systems conversion. Core deposits rose 5% annualized while brokered deposits fell to 6% of assets, improving funding quality. Operating earnings...
Newton Golf Company Inc (NWTG) Q4 2025 Earnings Call Transcript
Newton Golf Company reported Q4 2025 net income before taxes of $80 million, a 16.4% increase, and total revenue of $284 million, up 10.6% year‑over‑year. Diluted earnings per share surged 1,211% to $2.18, with 2026 guidance centered at $2.35. The firm added...
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Transcript
Co‑Diagnostics reported Q2 2025 revenue of $200,000, a sharp drop from $2.7 million a year earlier after grant funding disappeared. Operating expenses were reduced to $8.2 million, yielding a cash balance of $13.4 million, while the net loss widened slightly to $7.7 million. Management outlined...
Nike Inc (NKE) Q3 2026 Earnings Call Transcript
Nike reported Q3 FY26 revenue of $12.39 billion, essentially flat and down 3% on a currency‑neutral basis. Gross margin slipped to 40.2%, a 130‑basis‑point decline driven largely by a 300‑basis‑point tariff impact in North America. Nike Direct sales fell 7% while...
Femasys Inc (FEMY) Q4 2025 Earnings Call Transcript
Viemed Healthcare reported record full‑year revenue of $270.3 million, up 21% YoY, and adjusted EBITDA of $61.4 million, delivering a 22.7% margin. The company accelerated diversification, with sleep therapy patient counts rising 62% and maternal‑health revenue contributing $9 million, while ventilation’s share of...
BIO-Key International Inc (BKYI) Q4 2025 Earnings Call Transcript
BIO-key International reported a 49% year‑over‑year revenue increase to $1.7 million in Q2 2025, driven primarily by hardware sales and expanding defense contracts. Gross profit rose 40% despite a margin dip to 73% as the hardware mix grew. Operating expenses fell...
Chagee Holdings Ltd (CHA) Q4 2025 Earnings Call Transcript
Chegg reported $18 million in Q4 2025 revenue from its newly emphasized Chegg Skilling unit, signaling the start of double‑digit growth in the $40 billion corporate‑learning market. Adjusted EBITDA reached $13 million, an 18% margin that exceeded the high end of guidance,...
Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Transcript
OrthoPediatrics Corp. reported fourth‑quarter 2025 revenue of $61.6 million, a 17% year‑over‑year increase driven by strong performance across trauma, deformity, scoliosis and specialty bracing segments. The quarter marked the company’s first positive free‑cash‑flow generation, delivering $10 million, while adjusted EBITDA rose 59%...
Sportsman's Warehouse Holdings Inc (SPWH) Q4 2026 Earnings Call Transcript
Sportsman's Warehouse reported net sales of $331.3 million, up 2.2% year‑over‑year, marking a third straight quarter of positive same‑store sales growth. Category strength came from fishing (+14%) and hunting/shooting (+5%), while e‑commerce rose 8% and gross margin improved to 32.8%, a...
Skillz Inc (SKLZ) Q4 2025 Earnings Call Transcript
Playtika reported Q4 2025 revenue of $678 million, a modest sequential rise and 4.4% year‑over‑year growth, driven largely by a 19.5% jump in direct‑to‑consumer (D2C) sales. Casual titles now account for 74% of total revenue, reflecting a strategic pivot away from...
PVH Corp (PVH) Q4 2026 Earnings Call Transcript
G-III Apparel Group reported fourth‑quarter net sales of $771 million, a 8% decline year‑over‑year, as the company completed its exit from Calvin Klein and Tommy Hilfiger licenses, shedding $254 million in revenue. Owned brands such as DKNY, Donna Karan, Karl Lagerfeld and Vilebrequin now...
Cyclerion Therapeutics Inc (CYCN) Q4 2025 Earnings Call Transcript
CION Investment Corp reported a 7.4% sequential drop in NAV per share to $13.76, driven primarily by unrealized mark‑to‑market adjustments in a handful of equity holdings. The firm’s first‑lien loan portfolio, which makes up about 81% of assets, saw weighted...
Kairos Pharma Ltd (KAPA) Q4 2025 Earnings Call Transcript
Karyopharm Therapeutics posted Q4 2025 revenue of $34.1 million, an 11.8% year‑over‑year increase, while total 2025 revenue reached $146.1 million. Operating efficiency improved, with R&D and SG&A expenses down 17% and 16% respectively, yet the company recorded a GAAP net loss of...
Meridian Holdings Inc (MRDN) Q4 2025 Earnings Call Transcript
Sound Point Meridian Capital reported a sharp decline in net asset value to $14.02 per share for Q4 2025, driven by mark‑to‑market pressure on CLO equity valuations as buyer demand faded. Net investment income of $9 million fell short of the...
Solesence Inc (SLSN) Q4 2025 Earnings Call Transcript
Solesence Inc. reported Q4 2025 revenue of $14.5 million, a 14% year‑over‑year decline, with gross margin falling to 23% from 36% and a net loss of $1.1 million. The company highlighted a surge in open orders to $64 million, reflecting continued demand...
AlTi Global, Inc (ALTI) Q4 2025 Earnings Call Transcript
AlTi Global reported full‑year 2025 revenue of $4.6 billion, its highest since 2012, and an adjusted EBITDA margin of 19.7%, up 180 basis points year‑over‑year. The company’s aerospace and defense mix rose to 68% of sales and is projected to exceed...
Brainstorm Cell Therapeutics Inc (BCLI) Q4 2025 Earnings Call Transcript
Bristol‑Myers Squibb reported flat Q4 2025 revenue of $12.5 billion, with its growth portfolio expanding 15% YoY to $7.4 billion, offsetting roughly $4 billion of legacy decline. The company guided 2026 revenue between $46 billion and $47.5 billion, projecting 10‑15% growth for Eliquis despite a...
Purple Innovation Inc (PRPL) Q4 2025 Earnings Call Transcript
Purple Innovation reported a blockbuster fourth quarter, delivering $124.3 million in revenue—a 58.3% year‑over‑year jump—and closed 2019 with $428.4 million net revenue, up 49.9% from the prior year. Gross margin expanded to 47.7% in Q4 and 44.1% for the full year, driven...
Bioatla Inc (BCAB) Q4 2025 Earnings Call Transcript
BioAtla reported that it is in the final stages of a strategic partnership transaction expected to close by year‑end and disclosed FDA alignment on the phase‑3 design of its OSFI (OSV) trial for second‑line oropharyngeal squamous cell carcinoma. The trial...
T Stamp Inc (IDAI) Q4 2025 Earnings Call Transcript
TTM Technologies posted Q4 2025 net sales of $774.3 million, a 19% year‑over‑year increase driven by data‑center, networking, and aerospace & defense demand. Non‑GAAP earnings per share reached a record $0.70, matching the top of guidance, while adjusted EBITDA margin rose...
DSS Inc (DSS) Q4 2025 Earnings Call Transcript
Distribution Solutions Group (DSG) reported fiscal 2025 revenue of $1.98 billion, up 9.8% despite one fewer selling day, and generated $84 million of operating cash flow. Adjusted EBITDA fell to $175 million, reflecting an 8.9% margin, down from 9.7% a year earlier, while...
Forum Markets, Inc (FRMM) Q4 2025 Earnings Call Transcript
Forum Energy Technologies (FET) posted Q4 2025 revenue of $202 million, up 3% sequentially and at the top of guidance, driven by a 78% surge in international sales. Adjusted EBITDA reached $23 million, also at the high end of forecasts, while free...
Birchtech Corp (BCHT) Q4 2025 Earnings Call Transcript
Ichor Holdings reported fourth‑quarter 2025 revenue of $223.6 million, bringing full‑year revenue to $948 million, a 12% year‑over‑year increase driven by strong etch and deposition sales. Gross margin improved to 11.7%, surpassing guidance by 70 basis points, while operating income reached $2.7 million...
McCormick & Company Inc (MKC) Q1 2026 Earnings Call Transcript
MSC Industrial Direct reported first‑quarter net sales of $966 million, meeting the midpoint of its guidance, with average daily sales up 4% year‑over‑year. Price increases contributed 4.2% to growth, partially offset by a 0.3% volume decline linked to a federal government...
Allbirds Inc (BIRD) Q4 2025 Earnings Call Transcript
Allbirds reported Q4 2024 net revenue of $56 million, in line with guidance, and a modestly better-than-expected adjusted EBITDA loss of $19 million. The company highlighted cost discipline, cutting SG&A by over $20 million and closing 15 U.S. stores while...
Interactive Strength Inc (TRNR) Q4 2025 Earnings Call Transcript
Integer Holdings reported an 8% rise in full‑year sales to $1.85 billion, with organic growth exceeding 6%, and a 21% jump in adjusted EPS to $6.40. Adjusted operating margin expanded to 17.3%, driven by higher gross margins and disciplined expense control....
Milestone Scientific Inc (MLSS) Q4 2025 Earnings Call Transcript
Milestone Scientific reported that the FDA accepted the New Drug Application for lorundrostat and set a PDUFA target date of December 22, 2026. The company highlighted a surge in cash to $656.6 million, extending its financial runway to 2028, while net...
T1 Energy Inc (TE) Q4 2025 Earnings Call Transcript
Energy Transfer reported a record full‑year Adjusted EBITDA of $16 billion, a 3% increase, and Q4 Adjusted EBITDA of $4.2 billion, surpassing the prior year. The company raised its 2026 Adjusted EBITDA outlook to $17.45‑$17.85 billion, driven solely by the USA Compression acquisition....
KORE Group Holdings Inc (KORE) Q4 2025 Earnings Call Transcript
KORE Group reported flat Q4 2025 revenue of $68.7 million, with IoT connectivity revenue holding steady and showing 1.7% sequential growth. Adjusted EBITDA improved 12% to $14.5 million, narrowing the net loss to $12.7 million thanks to cost cuts and...
HCW Biologics Inc (HCWB) Q4 2025 Earnings Call Transcript
Hercules Capital reported record Q4 2025 performance, originating $1.06 billion in new debt and reaching nearly $4 billion in annual originations. Platform‑level assets under management grew 20.5% to $5.7 billion, while GAAP leverage rose modestly to 104.4%, remaining at the low end of...
Safe Pro Group Inc (SPAI) Q4 2025 Earnings Call Transcript
Safehold Inc. reported a strong Q4 2025, closing ten transactions worth $167 million and securing a $400 million unsecured term loan that lifted year‑end liquidity to $1.2 billion. The company achieved a credit rating upgrade to A‑ from S&P and now holds single‑A...
Workhorse Group Inc (WKHS) Q4 2025 Earnings Call Transcript
Workhorse Group reported a challenging Q4 2024 but highlighted progress on its flagship W56 platform, launching a 208‑inch wheelbase model and securing an initial order for 13 step‑vans. The company received regulatory approval to sell the W750 and W56 step‑vans...
TD Synnex Corp (SNX) Q1 2026 Earnings Call Transcript
TD Synnex reported Q1 2026 net sales of $409.1 million, a 2.3% increase driven by foreign‑exchange and tariff pass‑through. The company posted a GAAP net loss of $4.1 million, narrowing sharply from last year, while adjusted EBITDA fell to $27.4...
ENDRA Life Sciences Inc (NDRA) Q4 2025 Earnings Call Transcript
Schneider National reported fourth‑quarter 2025 revenue of $1.3 billion, up 4% year‑over‑year, but adjusted earnings per share fell to $0.13, a 35% decline. The quarter was marred by a truncated peak season, severe Midwest weather, and auto‑production shutdowns that compressed margins,...
DSS Inc (DSS) Q3 2025 Earnings Call Transcript
DSS Inc reported a sharp rebound in bookings, up 42% sequentially and 35% year‑over‑year to $540 million, while revenue slipped to $923 million as shipments declined. The quarter posted a $16 million adjusted operating loss, largely due to $40 million in tariff expenses. Management...
Brag House Holdings Inc (TBH) Q4 2025 Earnings Call Transcript
Bread Financial reported a solid fourth‑quarter and full‑year 2025, with credit sales rising 3% to $27.8 billion and net income of $53 million excluding a $42 million debt‑repurchase charge. The company improved credit quality, cutting the net loss rate to 7.4% in Q4...
Centessa Pharmaceuticals PLC (CNTA) Q4 2025 Earnings Call Transcript
Centene reported full‑year 2025 adjusted diluted EPS of $2.08, while Q4 showed a $(1.19) loss driven by a $389 million divestiture charge. Management guided 2026 adjusted EPS above $3, implying more than 40% year‑over‑year growth, anchored by Medicaid margin stabilization and...
Mink Therapeutics Inc (INKT) Q4 2025 Earnings Call Transcript
MiNK Therapeutics reported a cash position of $14.3 million, extended through 2026 after a $1.2 million raise, while posting a $2.9 million net loss for Q4. Clinical data showed AGENT‑797 combined with PD‑1 achieved a median overall survival of roughly 23 months in heavily...